BIOMERIEUX 30/05/2017 AGM
O.1Approve Corporate Financial StatementsFor
O.2Discharge the BoardOppose
O.3Approve Consolidated Financial StatementsFor
O.4Approve Allocation of the IncomeFor
O.5Approve Transaction with Fondation MerieuxFor
O.6Approve Transaction with Fondation Cristophe et Rodolphe MerieuxFor
O.7Approve Compensation and Benefits Paid or Allocated to Jean-Luc Belingard, CEOOppose
O.8Approve Remuneration Policy for the CEOOppose
O.9Approve the Compensation and Benefits Paid or Allocated to Alexandre Merieux, Deputy General Manager Oppose
O.10Approve Remuneration Policy for The Deputy General Manager Oppose
O.11Approve Remuneration of Directors in the Aggregate Amount of EUR 400,000For
O.12Elect Marie-Paule KienyFor
O.13Elect Fanny LetierFor
O.14Appoint the Auditors: Grant ThorntonFor
O.15Decision Not to Renew PriceWaterHouseCoopers Audit SA as Alternate AuditorFor
O.16Authorize Repurchase of Up to 10 Percent of Issued Share CapitalOppose
E.17Amend Article 12Oppose
E.18Approve 3-for-1 Stock Split and Amend Bylaws AccordinglyFor
E.19Reduce Share Capital via Cancellation of Treasury SharesFor
E.20Issue Shares with Pre-emption Rights up to Aggregate Nominal Amount of EUR 4.21 MillionFor
E.21Issue Shares without Pre-emptive Rights up to Aggregate Nominal Amount of EUR 4.21 MillionOppose
E.22Approve Issue of Shares for Private PlacementOppose
E.23Approve Issue of Shares Deviating from Price Fixing ConditionsFor
E.24Authorise the Board to Increase the Number of Shares Issued in case of Exceptional DemandOppose
E.25Approve Issue of Shares for Contribution in KindOppose
E.26Authorize Capitalization of ReservesFor
E.27Issu Shares without Pre-emptive Rights Including by Companies Owning over 50 Percent of the Company Share Capital up to Aggregate Nominal Amount of EUR 4.21 MillionOppose
E.28Approve Issue of Shares for Employee Saving PlanOppose
E.29Delegation of Powers to the Board to Execute Item 28 AboveFor
E.30Set Total Limit for Capital IncreaseFor
E.31Authorize Filing of Required DocumentsFor